A Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of QY201 Tablets in Subjects With Non-Segmental Vitiligo
Abroad (travel likely)RecruitingPHASE2
Conditions
Adult Subjects With Non-Segmental Vitiligo
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The First Hospital of China Medical University, Shenyang, Liaoning, China